9. COMMITMENTS AND CONTINGENCIES (Details Narrative) (USD $)	12 Months Ended
Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Research and development expense	$ 12,681,049	$ 10,368,695	$ 11,745,629
Rent expense, including amortization of deferred rent	2,651,460	2,659,532	2,667,296
Total deferred rent asset	6,047,098	6,591,126
Deferred rent asset, non-current	5,448,381	5,939,358
R & D deferred rent liability	3,992	1,033
Deferred rent liability	12,412	15,479
Ergomed Collaborative Arrangement
Research and development expense	$ 838,000

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References+ Details